SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004964
Filing Date
2024-02-05
Accepted
2024-02-05 17:25:28
Documents
16
Period of Report
2024-02-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44017
2 ex99-1.htm EX-99.1 15056
  Complete submission text file 0001493152-24-004964.txt   292132

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20240205.xsd EX-101.SCH 3967
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20240205_def.xml EX-101.DEF 27426
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20240205_lab.xml EX-101.LAB 37886
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20240205_pre.xml EX-101.PRE 26043
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6758
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24596926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)